BUPRENORPHINE DOSING REGIME IN THE MANAGEMENT OF OUT-PATIENT HEROIN WITHDRAWAL
I tiakina i:
LINTZERIS, N., BUPRENORPHINE DOSING REGIME IN THE MANAGEMENT OF OUT-PATIENT HEROIN WITHDRAWAL. DRUG AND ALCOHOL REVIEW, Vol. 21, no. 1 (2002), p. 39-45.
Ref.
110130
Tauwāhi:
SIIS R.1025 Archivo
Palabras clave:
Buprenorfina, Desintoxicación, Dosis, Drogodependencias, Fármacos, Heroína, Opiáceos, Servicios ambulatorios, Síndrome de abstinencia, Tratamiento médico
Buprenorfina, Desintoxicación, Dosis, Drogodependencias, Fármacos, Heroína, Opiáceos, Servicios ambulatorios, Síndrome de abstinencia, Tratamiento médico
Ngā tūemi rite: BUPRENORPHINE DOSING REGIME IN THE MANAGEMENT OF OUT-PATIENT HEROIN WITHDRAWAL
- BUPRENORPHINE DOSING REGIME FOR INPATIENT HEROIN WITHDRAWAL: A SYMPTOM-TRIGGERED DOSE TITRATION STUDY
- OPIOID EFFECTS AND OPIOID WITHDRAWAL DURING A 24 H DOSING INTERVAL IN PATIENTS MAINTAINED ON BUPRENORPHINE
- SINGLE DOSE OF 24 MILLIGRAMS OF BUPRENORPHINE FOR HEROIN DETOXIFICATION: AN OPEN-LABEL STUDY OF FIVE INPATIENTS
- AN OPEN TRIAL OF LOW DOSE BUPRENORPHINE IN TREATING METHADONE WITHDRAWAL
- THE SUBJECTIVE OPIOID WITHDRAWAL SCALE 'SOWS'. EN:NATIONAL CLINIC GUIDELINES AND PROCEDURES FOR THE USE OF BUPRENORPHINE IN THE TREATMENT OF HEROIN DEPENDENCE
- THE OBJECTIVE OPIOID WITHDRAWAL SCALE 'OOWS'. EN:NATIONAL CLINIC GUIDELINES AND PROCEDURES FOR THE USE OF BUPRENORPHINE IN THE TREATMENT OF HEROIN DEPENDENCE